Inequalities in childhood vaccination are widening in England, with uptake rates of five key vaccines consistently lower in young children living in areas of higher deprivation from 2019 to 2023, finds a study published by The BMJ today.
Venous thromboembolism market projected to grow at 2.6% CAGR between 2022 and 2032 – Pharmaceutical Technology
Factor XI inhibitors are a key area for clinical trial development in VTE due to the associated decreased bleeding risk. Credit: Kateryna Kon via Shutterstock.